Tenet Healthcare director Nadja West sold $5.6 million in shares despite strong earnings and raised guidance.

Tenet Healthcare Director Nadja West sold 2,178 shares on December 15, 2025, reducing her stake by 7.1% to 28,480 shares, valued at about $5.62 million, according to an SEC filing. The stock closed at $195.12 on December 17, down $1.76. Tenet reported strong Q3 earnings, with $3.70 EPS and $5.29 billion in revenue, up 3.2% year-over-year, and raised its 2025 EPS guidance to $15.93–$16.26. The company has a market cap of $17.15 billion, a P/E ratio of 13.37, and a "Moderate Buy" consensus rating with a $230.88 target.